Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”
        Saved in:
      
    
          | Main Authors: | Yewan Park, Dong Hyun Sinn | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Korean Association for the Study of the Liver
    
        2024-10-01 | 
| Series: | Clinical and Molecular Hepatology | 
| Subjects: | |
| Online Access: | http://e-cmh.org/upload/pdf/cmh-2024-0519.pdf | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Nucleos(t)ide Analog Treatment Discontinuation in Chronic Hepatitis B Virus Infection: A Systematic Literature Review        
                          
 by: Robert Gish, et al.
 Published: (2025-01-01)
- 
                
                    Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B        
                          
 by: Qianqian Ma, et al.
 Published: (2025-02-01)
- 
                
                    Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapy        
                          
 by: Tingyan Wang, et al.
 Published: (2025-01-01)
- 
                
                    Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B        
                          
 by: Beatriz López Centeno, et al.
 Published: (2016-07-01)
- 
                
                    Switching to Tenofovir Therapy Versus Continuation of Entecavir for Patients With Hepatitis B Virus Infection: A Systematic Review and Meta‐Analysis        
                          
 by: Muhammad Shahzil, et al.
 Published: (2024-11-01)
 
       